SERB is a leading Pan-European specialty pharmaceutical group providing a reliable supply of prescription medicines to patients suffering from rare and life-threatening diseases. This consistent portfolio includes essential medical countermeasures against the CBRN threat at the core of our business.
With their extensive life-saving medicines, they are a long-standing partner for health authorities, governmental and non-governmental agencies, therapeutic experts, and patient associations – committed to serve each patient's needs.
The risk posed by CBRN is a permanent and unpredictable threat. With one of the most wide-ranging emergency care portfolios, SERB takes pride to protect everyone, everywhere – #Proudtosavelives.